Biosignature Discovery for Personalized Treatment in Depression (U01)

Image via Wikipedia

Purpose
The purpose of this initiative is to support exploratory research to discover panels of promising biomarkers (i.e., biosignatures) that are predictive of treatment outcomes in major depressive disorder.

Mechanism of Support:
This FOA will utilize the NIH Cooperative Agreement (U01) award mechanism. Funds Available and Anticipated Number of Awards: The NIMH expects to commit approximately $6 million in total costs in Fiscal Year 2010 to fund one or more U01 awards under this initiative.

Eligible Applicants
State governments,Public and State controlled institutions of higher education,Native American tribal governments (Federally recognized),Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education,Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education,Private institutions of higher education,For profit organizations other than small businesses,Others (see text field entitled "Additional Information on Eligibility" for clarification

Link to Full Announcement